PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Anaesthesiology and Intensive Care Medicine, University Hospital Tübingen, 9188Eberhard-Karls-University, Tübingen, Germany.\', \'Department I-General Pediatrics, Hematology/Oncology, University Children\'s Hospital Tübingen, Tübingen, Germany.\', \'Center for Clinical Transfusion Medicine, University of Tübingen, Tübingen, Germany.\', \'Transfusion Medicine, Medical Faculty of Tübingen, Tübingen, Germany.\', \'Innere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/0885066621997365
?:doi
?:hasPublicationType
?:journal
  • Journal of intensive care medicine
is ?:pmid of
?:pmid
?:pmid
  • 33663244
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.82
?:rankingScore_hIndex
  • 50
is ?:relation_isRelatedTo_publication of
?:title
  • Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33663244>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33663244>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all